Best peptides for sleep
Peptides researched for sleep quality, relaxation, and stress-related insomnia.
Sleep peptides target different mechanisms — from directly influencing sleep architecture to reducing the stress and anxiety that keep people awake. The evidence ranges from promising early research to very limited data.
An orally active growth hormone secretagogue that mimics ghrelin, the hunger hormone. Despite being widely sold alongside peptides and SARMs, MK-677 is technically a non-peptide small molecule. It was studied extensively but never FDA-approved, and carries significant metabolic concerns.
What evidence supports
- ✓consistently raises GH and IGF-1 levels in clinical studies
- ✓oral bioavailability is a significant practical advantage over injectable peptides
- ✓two-year study showed sustained IGF-1 elevation without tachyphylaxis
Key concern: significantly increases appetite — can lead to unwanted weight gain
A 9-amino acid neuropeptide produced in the hypothalamus and released from the pituitary. Naturally involved in childbirth, breastfeeding, and social bonding. Intranasal oxytocin has been extensively studied for autism spectrum disorder, social anxiety, and PTSD — with disappointing clinical trial results despite promising early findings.
What evidence supports
- ✓acute intranasal administration increases trust behavior in economic game paradigms (Kosfeld et al., Nature, 2005)
- ✓reduces amygdala activation to social threat stimuli in fMRI studies
- ✓IV oxytocin highly effective for labor induction and postpartum hemorrhage (obstetric use)
Key concern: early positive research on intranasal oxytocin has largely failed to replicate in larger controlled trials
A synthetic peptide derived from the naturally occurring immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics in Russia. Approved in Russia as an anxiolytic and nootropic. Gaining interest in Western biohacking communities for anxiety and cognitive support.
What evidence supports
- ✓approved as an anxiolytic medication in Russia based on clinical studies
- ✓demonstrated anxiolytic effects in multiple animal models
- ✓some human studies show reduced anxiety scores, though trials are small
Key concern: not FDA-approved or approved in most Western countries
A neuropeptide originally isolated from rabbit brain tissue in 1977, proposed to promote delta-wave (deep) sleep. Popular in biohacking circles for sleep optimization, though clinical evidence is mixed and methodologically weak.
What evidence supports
- ✓some human studies showed modest improvements in sleep onset and subjective sleep quality
- ✓demonstrated cortisol-lowering effects in small clinical studies
- ✓shown antioxidant and stress-protective properties in animal models
Key concern: human studies are small, old (mostly 1980s-90s), and methodologically limited
A synthetic tripeptide (Glu-Asp-Arg) developed by the Khavinson group at the St. Petersburg Institute of Bioregulation. Designed as a bioregulator for the pineal gland, claimed to support circadian rhythm, cognitive function, and antioxidant defense. Evidence comes primarily from Russian laboratory research with limited independent replication.
What evidence supports
- ✓in vitro: EDR peptide reduces oxidative stress markers in neural cell cultures
- ✓Russian clinical reports: improvements in sleep and cognitive metrics in elderly patients
- ✓animal studies: neuroprotective effects in ischemia models
Key concern: almost all evidence originates from the same Russian research group (Khavinson et al.) with limited independent verification
Not sure which is right for you?
Take our quiz for a personalized recommendation based on your goals and preferences.
Take the Peptide QuizMedical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.